"AI Will Change Not Only Drug Discovery but Development," Says US Company GEn1E Lifesciences Regarding End-typing Driven Drug Development

bio.nikkeibp.co.jp·August 5, 2026·1 min read

AI Summary

GEn1E Lifesciences in the US emphasizes that AI will transform both drug discovery and development. Their approach focuses on end-typing as a starting point for innovative drug development.

This story was originally published in another language — the summary above is an English translation. Read the full article at the source.

View original at bio.nikkeibp.co.jp

Keep reading

POSTECH develops distributed AI technology that detects label errors without sharing original dataetnews.com · 2h ago A quake shakes the throne of artificial intelligence: the founder of DeepMind steps down and Google experiences a leadership drainvetogate.com · 2h ago 2026 China Digital Industry Ecosystem Conference Held: AI Becomes the Underlying Foundation, Accelerating the Reconstruction of Industry Valuefinance.eastmoney.com · 2h ago Would you accept that your health data be used by AI?actu.orange.fr · 2h ago

Was this useful?